Article

Multimodal blood based profiling reveals insights into mechanisms of immunotherapy resistance

2025-04-22

Abstract excerpt

Many cancer patients treated with immune checkpoint blockade (ICB) do not have durable treatment responses. Circulating biomarkers have the potential to identify patients with primary resistance or early progression on therapy to alter treatment course and avoid unnecessary toxicity. Unbiased multimodal proteomic profiling in blood has been underexplored due to the previously limited scalability of multiplexing te...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e196400b-e3f0-5f0d-8500-5aef2040a1bb
DOI: 10.1101/2025.04.20.25325955

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multimodal blood based profiling reveals insights into mechanisms of immunotherapy resistanceDOI 10.1101/2025.04.20.25325955Read

Plasma proteomic biomarkers identify non-responders and reveal biological insights about the tumor microenvironment in melanoma patients after PD1 blockadeSemantic proximity Read

High IGKC Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint BlockadeSemantic proximity Read

B cells sustain inflammation and predict response to immune checkpoint blockade in human melanomaSemantic proximity Read

Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic cutaneous melanomaSemantic proximity Read

Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivitySemantic proximity Read

Multiplexed imaging mass cytometry reveals distinct tumor-immune microenvironments linked to immunotherapy responses in melanomaSemantic proximity Read

Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanomaSemantic proximity Read

Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironmentSemantic proximity Read

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma.Semantic proximity Read

Integrative single-cell profiling of melanoma reveals a tumor microenvironment signature predictive of immunotherapy responseSemantic proximity Read

NK cells contribute to resistance to anti-PD1 therapy in immune-excluded melanomasSemantic proximity Read

Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapySemantic proximity Read